GSK
GSK
GSK
909 hedge funds and large institutions have $13.3B invested in GSK in 2024 Q1 according to their latest regulatory filings, with 99 funds opening new positions, 325 increasing their positions, 300 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2% more funds holding
Funds holding: 894 → 909 (+15)
8% more repeat investments, than reductions
Existing positions increased: 325 | Existing positions reduced: 300
0.23% more ownership
Funds ownership: 7.28% → 7.51% (+0.23%)
Holders
909
Holding in Top 10
14
Calls
$195M
Puts
$109M
Top Buyers
| 1 | +$363M | |
| 2 | +$215M | |
| 3 | +$81M | |
| 4 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$62.4M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$58.8M |
Top Sellers
| 1 | -$191M | |
| 2 | -$112M | |
| 3 | -$59.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$55.8M |
| 5 |
MIS
Morningstar Investment Services
Chicago,
Illinois
|
-$52.6M |